313 related articles for article (PubMed ID: 11397651)
1. Tuberous sclerosis gene products in proliferation control.
Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M
Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651
[TBL] [Abstract][Full Text] [Related]
2. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
Miloloza A; Kubista M; Rosner M; Hengstschläger M
J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
[TBL] [Abstract][Full Text] [Related]
3. The cell cycle and tuberous sclerosis.
Hengstschläger M; Rosner M
Prog Cell Cycle Res; 2003; 5():43-8. PubMed ID: 14593699
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
5. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
van Slegtenhorst M; de Hoogt R; Hermans C; Nellist M; Janssen B; Verhoef S; Lindhout D; van den Ouweland A; Halley D; Young J; Burley M; Jeremiah S; Woodward K; Nahmias J; Fox M; Ekong R; Osborne J; Wolfe J; Povey S; Snell RG; Cheadle JP; Jones AC; Tachataki M; Ravine D; Sampson JR; Reeve MP; Richardson P; Wilmer F; Munro C; Hawkins TL; Sepp T; Ali JB; Ward S; Green AJ; Yates JR; Kwiatkowska J; Henske EP; Short MP; Haines JH; Jozwiak S; Kwiatkowski DJ
Science; 1997 Aug; 277(5327):805-8. PubMed ID: 9242607
[TBL] [Abstract][Full Text] [Related]
6. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
Sampson JR
Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
Soucek T; Yeung RS; Hengstschläger M
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15653-8. PubMed ID: 9861025
[TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis as an underlying basis for infantile spasm.
Yeung RS
Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
[TBL] [Abstract][Full Text] [Related]
9. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation.
Tapon N; Ito N; Dickson BJ; Treisman JE; Hariharan IK
Cell; 2001 May; 105(3):345-55. PubMed ID: 11348591
[TBL] [Abstract][Full Text] [Related]
10. The tuberous sclerosis complex genes in tumor development.
Mak BC; Yeung RS
Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic advances in tuberous sclerosis.
Cheadle JP; Reeve MP; Sampson JR; Kwiatkowski DJ
Hum Genet; 2000 Aug; 107(2):97-114. PubMed ID: 11030407
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
[TBL] [Abstract][Full Text] [Related]
13. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
[TBL] [Abstract][Full Text] [Related]
14. The TSC1 gene product, hamartin, negatively regulates cell proliferation.
Miloloza A; Rosner M; Nellist M; Halley D; Bernaschek G; Hengstschläger M
Hum Mol Genet; 2000 Jul; 9(12):1721-7. PubMed ID: 10915759
[TBL] [Abstract][Full Text] [Related]
15. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
16. TSC1 and TSC2 gene mutations in human kidney tumors.
Kajino K; Hino O
Contrib Nephrol; 1999; 128():45-50. PubMed ID: 10597376
[No Abstract] [Full Text] [Related]
17. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38.
Rosner M; Hofer K; Kubista M; Hengstschläger M
Oncogene; 2003 Jul; 22(31):4786-98. PubMed ID: 12894220
[TBL] [Abstract][Full Text] [Related]
18. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
Aicher LD; Campbell JS; Yeung RS
J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
20. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
